-
Uncategorized2 weeks ago
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca
Like its pharma peers, Novartis is pouring money into Chinese operations, including expansions and upgrades at an existing manufacturing facility.
-
Uncategorized2 weeks ago
Aardvark Pauses 2 Obesity Trials, Reveals New Details on Cardiac Concerns
Aardvark Therapeutics’ obesity asset is based on its lead molecule, which in February was linked to reversible heart safety signals in a healthy volunteer study.
-
Endpoints News2 weeks ago
XO Health to expand its alternative health plan nationwide
XO Health, a startup offering an alternative health plan, is gearing up to work with self-insured employers and plan administrators nationwide. The startup is expanding its...
-
Uncategorized2 weeks agoResearch uncovers how prostate cancer cells resist treatment
Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate cancer cells—an important process that may help explain how some...
-
Endpoints News2 weeks ago
Triangle Health raises $4M as people turn to AI to understand their health
Triangle Health raised $4 million to help people understand their health conditions and explore treatment options, Endpoints News learned exclusively. After a person uploads their health...
-
Fierce Biotech2 weeks ago
GE HealthCare claims photon-counting CT clearance from FDA
The new Photonova Spectra aims to capture up to 50 times more data than some of its premium CT predecessors.
-
Uncategorized2 weeks ago
Gilead Chief Gets 20% Pay Bump, Still Falls Short of $30M Club
Gilead’s median employee compensation in 2025 was $238,979. Daniel O’Day’s compensation package is 119 times larger.
-
Uncategorized2 weeks ago
Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos
Following last month’s $7.8 billion purchase of CAR T biotech Arcellx, Gilead’s dealmaking train chugs along with yet another acquisition—this time securing Ouro Medicines’ pipeline of...
-
GEN – Genetic Engineering & Biotechnology News2 weeks agoModified Lipid Nanoparticles Boost mRNA Vaccine Delivery to Lymph Nodes
Lipid nanoparticles have become the workhorse of mRNA vaccines, ferrying genetic cargo into cells so the immune system can learn to recognize a threat. But most...
-
GEN – Genetic Engineering & Biotechnology News2 weeks ago
Synthetic DNA Manufacturing Hub Set Up in Boston by Artis BioSolutions
Artis BioSolutions, an advanced therapies company in San Diego, established new synthetic DNA manufacturing capabilities in Boston utilizing Bilbao, Spain-based Syngoi Technologies’ proprietary enzymatic platform. This...
